Introduction
The evolutionarily conserved mitogen-activated protein kinase (MAPK) cascades consist of tiered protein kinases that undergo sequential phosphorylation and activation, allowing specific signal amplification to elicit a corresponding cellular response (Kyriakis and Avruch, 2001; Winter-Vann and Johnson, 2007) . Each cascade module consists of an MAPK, an MAPK kinase (MAP2K), and an MAPK kinase kinase (MAP3K).
MAPK cascades are activated by diverse stimuli to mediate multiple signaling pathways, resulting in a crucial impact on cell fate processes such as cell growth, differentiation and death. Among the MAPK cascades, those triggered by the MAP3K apoptosis signal-regulating kinase 1 (ASK1) are critical determinants of apoptosis (Wang et al., 1996; Ichijo et al., 1997; Takeda et al., 2008) . ASK1 activation leads to phosphorylation and activation of MAP2K4/7 or MAP2K3/6 and the resulting MAPKs c-Jun N-terminal kinase (JNK) and p38 activation, respectively. A variety of intrinsic and extrinsic cellular stress stimuli induce ASK1 activation. For example, ASK1 relays signals from death receptors, such as those activated by tumor necrosis factor a (Chang et al., 1998) . ASK1 is also activated by unfolded protein response-induced endoplasmic reticulum stress (Nishitoh et al., 2002) . Recently, important physiological and pathological roles of ASK1 have emerged to include the regulation of innate immunity, cellular differentiation, and various human diseases such as cardiac hypertrophy and remodeling, insulin resistance, neurodegeneration and tumorigenesis (Izumiya et al., 2003; Matsuzawa et al., 2005; Imoto et al., 2006; Osaka et al., 2007; Iriyama et al., 2009) . Because of its importance as a central mediator of diverse developmental and stress signals, ASK1 activation is tightly controlled. The newly defined ASK1 signalosome reflects the numerous phosphorylation and protein interaction events critical to maintain ASK1 regulation (Takeda et al., 2007) .
One important ASK1 regulatory protein is 14-3-3, a phosphoserine/threonine-recognition protein (Fu et al., 2000; Yaffe, 2002; Mackintosh, 2004; Muslin and Lau, 2005; Aitken, 2006; Gardino et al., 2006; Morrison, 2009 ). 14-3-3 is a multifunctional regulatory protein that is important in maintaining a multitude of cellular processes, including cell cycle control, cell proliferation and inhibition of apoptosis. Seven mammalian isoforms of 14-3-3 have been identified and are denoted by Greek lettering (g, t, z, s, b, e, Z). 14-3-3 binds to the majority of its cellular ligands through a phosphorylated motif. The canonical 14-3-3 recognition motif has been identified as RSXpSXP, in which phosphorylation of the second serine is critical for 14-3-3 recognition (Muslin et al., 1996; Yaffe et al., 1997) . Binding of 14-3-3 to ASK1 through a phosphorylated S967 motif (RSIS 967 LP) has been shown to decrease ASK1 kinase activity and inhibit ASK1-induced apoptosis (Zhang et al., 1999a (Zhang et al., , 2003 Goldman et al., 2004) .
Recently, another MAP3K, ASK2, was found to bind with ASK1 (Wang et al., 1998b) . ASK2 has been shown to function as a tumor suppressor in combination with ASK1, and ASK2 levels are reduced in human gastrointestinal cancers (Iriyama et al., 2009) . The heteromeric complex of ASK1 and ASK2 is thought to have reciprocal functionality, which means that ASK1 and ASK2 function to activate each other (Osaka et al., 2007) . ASK2 activation of ASK1 is mediated by phosphorylation of T838 within the activation loop of the human ASK1 kinase domain, whereas ASK1 activation of ASK2 seems to occur through a phosphorylationindependent mechanism. Thus, dissection of ASK1-associated protein interactions may offer opportunities to gain further understanding of the general mechanisms controlling signal transmission through MAP3Ks.
Here we describe a novel mechanism by which ASK2 suppresses ASK1 function through the induced recruitment of 14-3-3 proteins. Our work establishes a new signaling complex consisting of ASK2, ASK1 and 14-3-3, suggests an inhibitory function of ASK2 for ASK1, and reveals a dynamic signal-relay function for the family of 14-3-3 proteins.
Results

ASK2 specifically interacts with 14-3-3 proteins
In our mechanistic study of the ASK1 signalosome, we noticed the presence of a putative 14-3-3 recognition motif surrounding S916 (RSPS 916 SP) in the C-terminus of ASK2. This motif fits well with the defined consensus 14-3-3 binding motif, RSXpSXP, and raises the possibility of ASK2 as a new 14-3-3 target protein (Gardino et al., 2006) . To test whether ASK2 interacts with 14-3-3, we carried out a series of affinity pulldown assays using Ni 2 þ -charged resin to isolate hexahistidine (6xHis) tagged 14-3-3g protein complexes from COS7 cell lysates. 14-3-3g K50E, a ligand-binding defective mutant, was used as a control (Thorson et al., 1998; Zhang et al., 1999b) . As revealed by western blot, glutathione S-transferase (GST)-ASK2 was found within the 14-3-3g wild-type (WT) complex, but was absent in the K50E complex (Figure 1a) , suggesting a specific interaction of ASK2 with 14-3-3g. Consistent with a potential role of ASK2 S916 in 14-3-3 binding, a truncated ASK2 lacking the sequence N-terminal to the kinase domain (ASK2-KC: 638-1288 aa) was still capable of binding with 14-3-3g ( Figure 1a ). To confirm this interaction, a reciprocal experiment was performed. When Flag-ASK2-KC was isolated from COS7 cell lysates using co-immunoprecipitation (co-IP), 14-3-3g WT, but not K50E, was found in the resulting ASK2 protein complex (Figure 1b) . In further support of these results, 14-3-3g was also able to pull down endogenous ASK2 (Figure 1c) . Together, the above data suggest that ASK2 specifically interacts with 14-3-3g through a binding site mapped to the KC fragment of the ASK2 protein. Therefore, ASK2-KC was used to further characterize binding with 14-3-3 in subsequent experiments. Figure 1 Interaction of apoptosis signal-regulating kinase 2 (ASK2) with 14-3-3 proteins. (a) ASK2 is in complex with 14-3-3g. COS7 cells were co-transfected with either glutathione S-transferase (GST)-ASK2 or GST-ASK2-KC and hexahistidine (6xHis)-14-3-3g wild type (WT) or K50E. The 14-3-3 protein complex was isolated 40 h after transfection with Ni 2 þ -charged resin and bound ASK2 was visualized by western blot. (b) 14-3-3 binds to ASK2 in a reverse co-immunoprecipitation (co-IP) assay. COS7 cell lysates overexpressing Flag-ASK2-KC and 6xHis-14-3-3g WT or K50E were used to isolate the ASK2-KC complex with an anti-Flag antibody. The resulting ASK2 protein complex was used for the detection of 14-3-3 by western blot. (c) 14-3-3 specifically binds endogenous ASK2. COS7 cells were transfected with 6xHis-14-3-3g (WT or K50E). The 14-3-3 g complex was isolated with Ni 2 þ -charged resin, and endogenous ASK2 was detected by western blot. (d) Interaction of ASK2 with multiple 14-3-3 isoforms. The isolation of the 14-3-3 isoform complex and the detection of ASK2 in each 14-3-3 complex were determined as in (a). (e) Competitive binding of ASK2 to 14-3-3 with defined 14-3-3 peptide antagonists. The 14-3-3/ASK2 complexes were isolated with an affinity pulldown assay as in (a), either in the presence or in the absence of antagonistic peptides (pSer259Raf and R18). Non-phosphorylated Raf peptide (Raf) or a randomized R18 peptide (R18rand) was used as control.
There are seven 14-3-3 isoforms in mammalian cells (g, t, z, s, b, e, Z). 14-3-3 interaction with ASK2 is not unique to the g isoform, as ASK2 was found in complex with all seven 14-3-3 isoforms (Figure 1d ). These data imply that ASK2 may use a common binding site within 14-3-3 proteins, such as the conserved amphipathic groove within the 14-3-3 structure (Gardino et al., 2006) . To test this possibility, we used two approaches: peptide competition assay and mutational analysis. Indeed, two well-defined 14-3-3 groove-binding peptides, a phosphorylated Raf peptide (pSer259-Raf) and an unphosphorylated antagonist peptide (R18), effectively competed away ASK2's interaction with 14-3-3g ( Figure 1e ) (Muslin et al., 1996; Petosa et al., 1998; Wang et al., 1999) . Conversely, inclusion of the respective peptide controls, unphosphorylated Raf peptide (Raf) or randomized R18 peptide (R18rand), showed no competitive effect. In further support of the involvement of the amphipathic groove in ASK2 binding, several charge-reversal mutations of 14-3-3z amino acid residues within the groove (K49E, R56E, R60E, V176D) greatly diminished interaction with ASK2 (data not shown; Wang et al., 1998a, b; Zhang et al., 1999b) . These data show how the amphipathic groove of 14-3-3 proteins is used as an ASK2 docking site, allowing common and specific binding between 14-3-3 and ASK2.
ASK2 requires phosphorylation for 14-3-3 binding
We found that incubation of cell lysates at 37 1C led to a decrease in ASK2's interaction with 14-3-3g ( Figure 2a ). This decrease is likely due to the increased action of an endogenous protein phosphatase(s), as the presence of a consensus motif (RSPS 916 SP) within ASK2 predicts a phosphorylation requirement for recognition by 14-3-3. In support of this notion, the inclusion of general phosphatase inhibitors during this incubation prevented the dissociation (Figure 2a ). The phosphorylation dependence of the interaction was further confirmed in a separate assay, in which calf intestinal phosphatase was shown to accelerate the dissociation of ASK2 from 14-3-3 (data not shown). This phenomenon allowed the use of more specific phosphatase inhibitors to validate the requirement of phosphorylation for the interaction and to define the class of protein phosphatases involved. At lower concentrations, okadaic acid is more specific for inhibition of the PP1/PP2A phosphatase family, whereas cyclosporine A is specific for inhibition of PP2B, or calcineurin (Cohen et al., 1989) . Treatment of cells with okadaic acid, but not cyclosporine A, led to a dramatic increase in the amount of the ASK2/14-3-3g complex ( Figure 2b ). From these data, we conclude that ASK2's interaction with 14-3-3 is negatively regulated by the PP1/PP2A phosphatase family, supporting the importance of a regulated phosphorylation dictating the ASK2/14-3-3 interaction.
14-3-3 binds ASK2 through a novel S964-mediated motif Both the phosphorylation dependence of the ASK2/14-3-3 interaction and the presence of a putative 14-3-3 binding motif within the ASK2 sequence (RSPS 916 SP) predict the importance of S916 as the critical phosphoacceptor mediating 14-3-3 interaction (Figure 3a) . To test whether the S916-containing motif is indeed an essential determinant of 14-3-3 interactions, we performed a competitive binding assay using a phosphorylated peptide representing the residues surrounding S916 (pSer916-ASK2). Unexpectedly, this peptide failed to compete with ASK2 for 14-3-3 binding, even at concentrations up to 100 mM (Figure 3b ). Intriguingly, this peptide also did not disrupt the interaction of 14-3-3 with Raf-1, another well-defined 14-3-3 client protein.
However, it remained possible that this peptide did not have the correct conformation for effective competition. To specifically test whether ASK2 S916 was necessary for 14-3-3 binding, we performed site-directed mutagenesis to generate a nonphosphorylatable GST-ASK2 S916A mutant. GST-ASK2 S916A was fully capable of binding to 14-3-3g (Figure 3c ). We also mutated the serines within and around this predicted 14-3-3 binding motif in ASK2, generating S912A, S914A and S917A. However, none of these mutations showed any effect on the ASK2/14-3-3 association (Figure 3c ). The failure of these mutations to inhibit ASK2 binding with 14-3-3, together with the lack of peptide competition using the putative phosphorylated motif, suggests that 14-3-3 targets a structure other than the S916-mediated motif for binding.
In search of the 14-3-3 binding site, we generated a series of deletion mutants within GST-ASK2-KC to further narrow down the binding region (depicted in Figure 2 The apoptosis signal-regulating kinase 2 (ASK2)/14-3-3 interaction requires phosphorylation. (a) Phosphatase inhibition increased the amount of ASK2/14-3-3 interaction. Cell lysates with co-expressed glutathione S-transferase (GST)-ASK2-KC and hexahistidine (6xHis)-14-3-3g were divided into two samples, and incubated at 37 1C either in the presence or in the absence of 50 mM phosphatase inhibitors (Na 4 P 2 O 7 , NaF, Na 3 VO 4 ). The lysate was removed at the indicated times and subjected to affinity pulldown and western blot as in Figure 1a . (b) An inhibitor of the protein phosphatase 2A family blocks ASK2's dissociation from 14-3-3. Cells co-expressing GST-ASK2-KC and 6xHis-14-3-3g were treated with increasing concentrations of either okadaic acid or cyclosporine A (Sigma), or vehicle (ethanol or methanol, respectively), for 1 h. Cell lysates were used in an affinity pulldown assay as described in Figure 1a .
ASK1/ASK2/14-3-3 ternary complex LM Cockrell et al Figure 3a ). Using these truncations, we localized the binding site within the ASK2 sequence between N937 and V973 (data not shown). Examination of the amino acid sequence within this region revealed that the most likely site for 14-3-3 recognition was a motif surrounding serine 964 (RCLS 964 YG; Figure 3a) . We then mutated the S964 residue to alanine (S964A), and used this mutant in an affinity pulldown assay. Mutation of this site did not affect the autokinase activity of ASK2 (Supplementary Figure S1) . However, the single S964A point mutation alone was sufficient to diminish ASK2's interaction with 14-3-3 (Figure 3d ), suggesting that phosphorylation at S964 has an essential function in 14-3-3 binding. Although minimal 14-3-3 binding was still seen to the S964A mutant, the significant loss of binding indicates that S964 is a critical 14-3-3 binding site. Thus, this study identifies S964 as the primary 14-3-3 recognition site within the ASK2 protein, and defines a novel, noncanonical 14-3-3 motif that may be present in other 14-3-3 client proteins.
14-3-3 is present in a ternary complex with ASK1 and ASK2 It is interesting to note that 14-3-3 interacts with both ASK2 and ASK1 (Zhang et al., 1999a) (Figure 1 ). This suggests the possibility of the formation of an ASK2/ ASK1/14-3-3 ternary complex within the ASK1 signalosome. To test this model, affinity pulldown assays were performed with COS7 cell lysates transfected with HA-ASK1, GST-ASK2 and 6xHis-14-3-3g. Indeed, both ASK1 and ASK2 were present in the resulting 14-3-3 protein complex (Figure 4a ). This complex occurred independently of the expression of either the fulllength or the KC versions of GST-ASK2. Further, this ternary complex was confirmed with reverse pulldown assays, which showed that 14-3-3 and ASK1 were found in the GST-ASK2 complex, and 14-3-3 and ASK2 were in the HA-ASK1 complex (data not shown). Neither ASK1 nor ASK2 was present in the 6xHis-14-3-3g K50E pulldown, suggesting that the ternary complex was mediated specifically by the amphipathic groove of 14-3-3. However, the above results did not rule out the possibility that ASK1/14-3-3 and ASK2/14-3-3 may be present in separate binary protein complexes. We therefore set out to test the specificity and functional significance of this ternary complex.
ASK2/14-3-3 interaction dictates ASK1/14-3-3 interaction The interaction of 14-3-3 with both ASK2 and ASK1 is dynamically regulated by phosphorylation through S964 of ASK2 and S967 of ASK1 (Zhang et al., 1999a) (Figure 3d ). Point mutation of these sites to alanine allows the generation of ASK1 or ASK2 proteins that are specifically defective in 14-3-3 binding, permitting the examination of 14-3-3's contribution to the ASK1/ ASK2 complex. We used 14-3-3-binding defective mutants of ASK1 (S967A) and ASK2 (S964A) to establish the interplay among 14-3-3, ASK2 and ASK1 in the ternary protein complex. These point mutations Competition with a pSer916-ASK2 peptide (NH2-CQPGKRSRSPpSSPRH-COOH) has no effect on the interaction of ASK2 with 14-3-3. Experiments were performed as in Figure 1d , and the 14-3-3/Raf-1 interaction was used as a control. (c) Mutations in the S916 motif of ASK2 fail to disrupt 14-3-3 binding. Point mutations were generated as shown, and the presence of mutated ASK2 in the 14-3-3 complex was determined as in Figure 1a . (d) ASK2 S964A abolishes binding to 14-3-3. COS7 cells were co-transfected with 6xHis-14-3-3g and glutathione S-transferase (GST)-ASK2 and GST-ASK2-KC wild-type (WT) or S964A mutants. After transfection, cells were lysed and used in the previously described 14-3-3 affinity pulldown assay. Figure 4 Association of apoptosis signal-regulating kinase 2 (ASK2) with ASK1 and 14-3-3 in a ternary complex. (a) ASK2, ASK1 and 14-3-3 exist in a multi-protein complex. HA-ASK1 and glutathione S-transferase (GST)-ASK2 were co-transfected into COS7 cells with either hexahistidine (6xHis)-14-3-3g wild type (WT) or K50E. Cell lysates were used in a 14-3-3 affinity pulldown assay, and the presence of ASK1 and ASK2 was revealed by anti-HA and anti-GST antibodies in a western blot. (b) Phosphorylation status of ASK2 S964 controls the association of 14-3-3 with ASK1. COS7 cells were transfected with the expression plasmids for 6xHis-14-3-3g (WT or K50E), HA-ASK1 (WT or S967A) and GST-ASK2-KC (WT or S964A). 14-3-3g protein complexes were isolated by affinity pulldown and associated ASK1, ASK2 and Raf-1, and the phosphorylation status of ASK1 at S967 was detected using the respective antibodies by western blot. (c) Increased expression of ASK2 S964A is correlated with decreased association of ASK1 from 14-3-3. COS7 cells were co-transfected with HA-ASK1 WT and 6xHis-14-3-3g, along with increasing amounts of expression vectors for either GST-ASK2-KC WT or S964A. The amount of ASK1 in the resulting 14-3-3 affinity pulldown complex from each sample was determined as in Figure 1a. (d) Quantification of data from (c). The relative percentage of ASK1 in each 6xHis-14-3-3g pulldown sample is shown. Lysates containing GST-ASK2-KC WT and S964A are indicated by solid circles () and squares ('), respectively. (e) ASK2 S964A mutation diminishes the association between endogenous ASK1 and 14-3-3. HeLa cells were transfected with pcDNA or GST-ASK2-KC (WT or S964A). Following transfection, endogenous ASK1 was immunoprecipitated from the cell lysates using a specific anti-ASK1 antibody. Endogenous 14-3-3 in the ASK1 co-immunoprecipitation (co-IP) was detected with a pan anti-14-3-3 antibody by western blot. (f) ASK2 knockdown diminishes endogenous ASK1/14-3-3 binding. HeLa cells were transfected with shRNAmir constructs targeting ASK2 or pGIPz empty vector control. Cells were selected with puromycin, and endogenous ASK1 was immunoprecipitated from lysates using a specific anti-ASK1 antibody. Endogenous 14-3-3 in the ASK1 co-IP was detected with a pan anti-14-3-3 antibody by western blot.
ASK1/ASK2/14-3-3 ternary complex LM Cockrell et al did not affect the interaction between ASK1 and ASK2 (Supplementary Figure S2) . The ASK2/14-3-3 interaction seems to be independent of the ASK1/14-3-3 interaction, as overexpression of neither ASK1 WT nor S967A induced any detectable change in ASK2/14-3-3 binding (Figure 4b) . However, the ability of ASK2 to bind 14-3-3 showed a dramatic impact on 14-3-3's interaction with ASK1. As previously shown, ASK1 WT is associated with 14-3-3, whereas ASK1 S967A has diminished 14-3-3 binding (Zhang et al., 1999a) . Unexpectedly, when ASK2-KC WT was overexpressed along with ASK1 S967A and 14-3-3g, ASK1 S967A was found in the 14-3-3g complex (Figure 4b ). One explanation for these results is that enhanced ASK2 WT expression increased the amount of ASK1 S967A in the ASK2/ASK1 protein complex, which was then pulled down with 14-3-3. However, overexpression of mutated ASK2 (S964A) dramatically decreased the amount of ASK1 WT in the 14-3-3 complex, lending strong support to a functional and regulated ternary protein association (Figure 4b) . Importantly, the effect of ASK2 S964A could be recapitulated with endogenous 14-3-3/ASK1 interaction as well (Figure 4e ). To further validate the ASK2 effect, dose-response experiments were carried out. Increasing amounts of ASK2 S964A, but not WT, led to a corresponding decrease in the amount of ASK1 appearing within the 14-3-3 complex (Figures 4c and d) .
We further explored the specificity of the ASK2/ ASK1/14-3-3 ternary complex formation by probing the effect of ASK2 or ASK1 on the interaction of 14-3-3 with Raf-1, another well-characterized MAP3K that binds 14-3-3. Interestingly, endogenous Raf-1 binding to 14-3-3 was unaffected by the overexpression of either WT or mutated ASK1 or ASK2 (Figures 4b and c) . These data suggest that the ASK2/ASK1/14-3-3 ternary complex is distinct from the 14-3-3/Raf-1 complex.
To further support the hypothesis that ASK2 regulates the ASK1/14-3-3 interaction, we performed ASK2 silencing experiments and examined the effect of reducing ASK2 on endogenous ASK1/14-3-3 binding (Figure 4f ). When ASK2 expression was knocked down, endogenous 14-3-3 binding to ASK1 was greatly reduced, indicating that ASK2 has a substantial role in regulating the interaction between these two proteins. Together, these results show that ASK2, ASK1 and 14-3-3 form a specific and unique ternary complex, in which the interaction between ASK2 and 14-3-3 determines the extent of ASK1 binding to 14-3-3.
ASK2/14-3-3 interaction controls ASK1 function Previous studies have shown that 14-3-3 binding suppresses ASK1 activity by maintaining S967 in a phosphorylated state, inhibiting ASK1-mediated JNK pathway activation (Zhang et al., 1999a (Zhang et al., , 2003 Min et al., 2008) . We reasoned that ASK2 might exert control over ASK1 by dictating the action of 14-3-3 within this ternary complex. To probe the functional consequence of the dynamically regulated ASK2/14-3-3 interaction, we examined the effect of the 14-3-3-binding defective mutant of ASK2 (S964A) on the phosphorylation status of ASK1 at S967 and the activation state of ASK1. Indeed, co-expression of ASK2 S964A resulted in a decrease in ASK1 S967 phosphorylation, an effect not observed on ASK2 WT expression (Figure 4b ). Although ASK1 S967A showed enhanced ASK1 activity (T838 phosphorylation) over ASK1 WT, the ASK1 WT activity was also stimulated on co-expression with ASK2 S964A, supporting an ASK2-mediated inhibitory role of 14-3-3 in the ternary complex (Figure 5a) .
As an additional biological readout of ASK1 activity, we monitored JNK activation. As we have previously shown, dephosphorylation of ASK1 at S967 is correlated with an increase in ASK1 kinase activity and ASK1-induced apoptotic signaling (Zhang et al., 1999a; Goldman et al., 2004) . After co-expression of ASK1 with ASK2 (WT or S964A), JNK activation was determined by western blot with an antibody directed against phosphorylated T183/Y185 of JNK (Figures 5b  and c) . Co-expression of ASK2-KC S964A showed a statistically significant increase in JNK activation (P ¼ 0.028) compared with ASK1 expression plus control pcDNA. No statistically significant increase in JNK activation was seen with expression of ASK2-KC S964A alone (P ¼ 0.130). These results indicate that ASK2's interaction with 14-3-3 is critical to allow 14-3-3 to engage and suppress ASK1, leading to a reduction in ASK1-mediated JNK signaling. Further evidence in support of a physiological role of an ASK2/14-3-3 connection in the regulation of the ASK1-JNK axis is provided by our peptide inhibitor study, in which disruption of the ASK2/ASK1 interaction was correlated with decreased ASK1/14-3-3 interaction and H 2 O 2 -induced JNK activation (M Puckett, L Cockrell and H Fu, unpublished data).
Discussion
Our data suggest a novel mechanism of ASK1 signalosome regulation, through ASK2-mediated recruitment of 14-3-3 proteins under certain physiological conditions, such as cells receiving survival signals (Figure 5d ). Our proposed model predicts an ASK2 kinase that phosphorylates S964 in response to a survival-promoting signal, which in turn induces association of ASK2 with 14-3-3 and recruits 14-3-3 to the ASK2/ASK1 complex. This allows 14-3-3 to bind to and suppress ASK1 through phosphorylated S967. Conversely, signals that promote dephosphorylation of ASK2 at S964 are expected to disengage 14-3-3 from ASK2, triggering 14-3-3's dissociation from the ASK1 complex. Once removed, the ASK1 signalosome is free of 14-3-3-imposed inhibition, allowing activation of downstream effector pathways, such as JNK stimulation. In this way, ASK2 functions as a dual regulator in the ASK1 signalosome: serving as an ASK1 activator under stress conditions (Takeda et al., 2007) while acting as an ASK1 suppressor by recruiting 14-3-3 under other conditions such as cell survival. Thus, ASK2 provides a signal integration point by which external or internal ASK1/ASK2/14-3-3 ternary complex LM Cockrell et al environmental signals are faithfully transmitted to ASK1 through engaging the phospho-binding protein 14-3-3, leading to either activation or suppression of ASK1 signaling. Even though 14-3-3 also interacts with another MAP3K Raf-1, the interaction status of ASK2 with 14-3-3 showed no obvious effect on the 14-3-3/ Raf-1 association, suggesting a functionally distinct ASK2/14-3-3/ASK1 signaling complex. Because 14-3-3 proteins bind most members of the MAP3K family, this may represent a general mechanism by which 14-3-3 and ASK2 exist in a heteromeric complex, and are dephosphorylated at S967 and S964, respectively. In this complex, ASK2 facilitates ASK1 activation through phosphorylation of T838, whereas ASK1 exhibits positive feedback regulation on ASK2 through stabilization of the ASK2 protein (Osaka et al., 2007) . These activities culminate in the activation of ASK1 downstream signals, leading to ASK1-induced apoptosis. Conversely, under conditions of cell survival, ASK2 S964 is phosphorylated through a pro-survival kinase-signaling cascade, generating a high-affinity 14-3-3 docking site. On phosphorylation at S964, ASK2 recruits 14-3-3 to the ASK2/ASK1 complex, leading to an interaction with ASK1 through phosphorylated S967 and subsequent suppression of the ASK1 signalosome.
ASK1/ASK2/14-3-3 ternary complex LM Cockrell et al regulates signal relay among MAP3Ks to ensure signaling integrity in various physiological processes.
Materials and methods
Cell culture, DNA transfection and plasmids COS7 and HeLa cells were maintained in Dulbecco's modified Eagle's medium and plasmid transfections were performed using FuGene6 or Fugene HD (Roche, Boulder, CO, USA) as previously described (Ichijo et al., 1997; Zhang et al., 1999a; Subramanian et al., 2004) . ASK2-KC and full-length ASK2 were amplified by PCR and cloned into the pDEST27 GST mammalian expression vector (Invitrogen, Carlsbad, CA, USA). Primer sequences are available in Supplementary data.
ASK2 knockdown
Plasmids encoding ASK2 shRNAmir constructs (RH54430-98513431 and RH54430-98903615) were purchased from Open Biosystems (Huntsville, AL, USA). HeLa cells were transfected with shRNAmir plasmid using Fugene HD (Roche) (Ichijo et al., 1997; Zhang et al., 1999a; Subramanian et al., 2004) . Transfected cells were selected with puromycin (2 mg/ml) for 3 days.
Protein interaction assays
Affinity pulldown assay. Cells were lysed in 200 ml of pulldown lysis buffer (Goldman et al., 2004) . HexaHis-tag fusion proteins in the clarified cell lysates were isolated with Ni 2 þ -charged resin (Novagen, Madison, WI, USA) as described (Subramanian et al., 2004) .
Co-IP assay. Cells were lysed in either 200 ml (COS7) or 1000 ml (HeLa) of co-IP lysis buffer (Goldman et al., 2004) . Cleared cell lysates were incubated with Protein A or G conjugated sepharose (GE Healthcare, Piscataway, NJ, USA) and the appropriate antibody for 2 h to overnight at 4 1C. Following incubation, the resin was washed three times with lysis buffer and protein samples were eluted by boiling in 6 Â SDS sample buffer for western blot analysis.
Phosphatase assay Cleared lysates of COS7 cells were divided into two samples, a 'plus inhibitors' sample with added phosphatase inhibitors (Na 4 P 2 O 7 , NaF, Na 3 VO 4 ), and a 'minus inhibitors' control sample. Time-course experiments were carried out as indicated. Lysates were then subjected to affinity pulldown as described above.
Western blotting
Proteins were separated on 8% or 12.5% SDS-PAGE gels and transferred to a nitrocellulose membrane, which were blocked with 5% milk. Membranes were probed overnight with anti-GST, anti-14-3-3 K19, anti-6xHis, anti-Raf anti-ASK1 (Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-Flag M2 (Sigma, St Louis, MO, USA), anti-ASK2 (Abnova, Taipei, Taiwan), or anti-phospho Ser967 ASK1 (Cell Signaling Technologies, Boston, MA, USA) antibodies, diluted in 5% milk. Corresponding horseradish peroxidaseconjugated secondary antibodies (Santa Cruz Biotechnology) were used against each primary antibody. Proteins were detected using West-Pico or West-Dura enhanced chemiluminescent detection reagents (Pierce, Rockford, IL, USA) and a Kodak imaging system. Densitometry was performed with Kodak 1D imaging software, and statistical analysis was carried out using the Student's t-test.
